Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 57Other solid neoplasm 57Sarcoma 2Gynecologic 2Gastrointestinal 2Breast 2Lymphoid 1Head & Neck 1Genitourinary 1Endocrine 1CNS 1

Conditions

Central Nervous System Neoplasms 36Neuroblastoma 35Brain Neoplasms 25Medulloblastoma 22Astrocytoma 10Glioma 8Glioblastoma 7Choroid Plexus Neoplasms 7Rhabdoid Tumor 6Oligodendroglioma 6Neuroectodermal Tumors, Primitive 6Ependymoma 6Breast Neoplasms 6Sarcoma 5Ovarian Neoplasms 5Neoplasms 5Ganglioneuroblastoma 5Esthesioneuroblastoma, Olfactory 5Carcinoma, Non-Small-Cell Lung 5Testicular Neoplasms 4Testicular Germ Cell Tumor 4Small Cell Lung Carcinoma 4Lung Neoplasms 4Head and Neck Neoplasms 4Gliosarcoma 4Thyroid Neoplasms 3Teratoma 3Squamous Cell Carcinoma of Head and Neck 3Seminoma 3Endodermal Sinus Tumor 3

Interventions

entinostat 1bemcentinib 1Tamoxifen 1Radiotherapy 1Fentanyl 1Erlotinib Hydrochloride 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × Cisplatin × CNS × Clear all
NCT00002608 2013-07-10

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
CNSEndocrineGastrointestinalHead & NeckOther solid neoplasmSarcomaThoracic

Familial ependymoma, Thyroid Cancer, Papillary, Mesothelioma, Malignant, Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Medulloblastoma, Oligodendroglioma, Pheochromocytoma, Sarcoma, Thyroid Neoplasms, Central Nervous System Neoplasms, Adenocarcinoma, Follicular, Adrenocortical Carcinoma, Carcinoma, Medullary, Glioma, Subependymal, Gliosarcoma, Optic Nerve Glioma, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡